Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
With opioid overdoses on the rise, knowing the facts and risks of fentanyl are crucial to EMS
In this quick clip, our co-hosts discuss a drug that is 10,000 time more powerful than morphine
Some departments pay over $100 per shot of Narcan; certain overdoses may require multiple treatments
Here is the “never-do” list if you want to have a long and prosperous career in EMS
Officials believe greater access to Narcan and a new good Samaritan law have saved lives
The new drug, PZM21, offers pain relief without causing a surge of dopamine
Officials suspected that a stronger cut of heroin was responsible for the spike in calls
As police become more active in Narcan saves, departments consider a new approach to the opioid crisis
Carfentanil is 100 times more potent than fentanyl, and requires multiple doses of Narcan to counteract
Community organizers are taking steps to deal with the state’s growing opioid epidemic
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.